2021
DOI: 10.1371/journal.pone.0251986
|View full text |Cite
|
Sign up to set email alerts
|

Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis

Abstract: Objectives We sought to systematically review the evidence supporting the role of drug coated balloons (DCBs) in the treatment of coronary bifurcation lesions. Background DCBs are emerging as an attractive alternative treatment strategy for treating coronary bifurcations due to simplifying the approach and reducing rates of stent related complications. We systematically reviewed the evidence for DCB use in coronary bifurcations and conducted a focused meta-analysis on late lumen loss in the side branch compa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 24 publications
0
17
0
Order By: Relevance
“…As a complement to a provisional stenting strategy, DCB remains very attractive for bifurcation lesion management. However, many questions, including selection for SB, technology (DCB with or without final kissing balloon or proximal optimization technology), and the actual impact on clinical endpoints remain unanswered ( 5 , 23 ). To date, studies exploring the efficacy of DCB in de novo coronary bifurcation lesions have many limitations, and no conclusive evidence has been provided.…”
Section: Discussionmentioning
confidence: 99%
“…As a complement to a provisional stenting strategy, DCB remains very attractive for bifurcation lesion management. However, many questions, including selection for SB, technology (DCB with or without final kissing balloon or proximal optimization technology), and the actual impact on clinical endpoints remain unanswered ( 5 , 23 ). To date, studies exploring the efficacy of DCB in de novo coronary bifurcation lesions have many limitations, and no conclusive evidence has been provided.…”
Section: Discussionmentioning
confidence: 99%
“…Although these results should be validated in large-scale RCTs with adequate sample sizes and longer follow-up durations, provisional stenting with DCB for SB protection may be applied as a promising treatment strategy for CBLs. Some previous meta-analyses evaluated the role of DCB in the treatment of CBLs [33][34][35]. Although these studies generally suggested a favorable role of DCB in improving the angiographic and/or clinical outcomes in patients with CBLs, the inclusion criteria of the meta-analyses were relatively extensive, and signifcant clinical heterogeneity could be observed among the included studies [33][34][35].…”
Section: Discussionmentioning
confidence: 99%
“…Corballis et al 43 observed that DCB outperformed POBA in the SB treatment for bifurcation in a focused meta-analysis. DCBs appear to be safe in the MB with improved SB LLL.…”
Section: Various Strategiesmentioning
confidence: 99%
“…This has been demonstrated in the recent meta-analysis. 43 It is indeed fascinating to see the scarce data for a DCB-only bifurcation strategy. DCB was found to be superior than POBA in the PEPCAD-BIF 30 trial whether used in either the SB or distal MB, however it included both small and large vessels.…”
Section: Proposed Dcb Strategies In Bifurcationmentioning
confidence: 99%
See 1 more Smart Citation